01167.HK
Jacobio Pharmaceuticals Group Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 6.44
+1.90%Margins
Gross margin
95.6%
EBITDA margin
49.2%
EBIT margin
45.4%
Net margin
49.6%
FCF margin
-20.1%
34.1%
Return on equity
24.8%
Return on assets
27.9%
Return on invested capital
0.59x
Asset turnover
-HKD 217.0M
Cash from operations
HKD 2.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026